{
  "question_stem": {
    "en": "A 35-year-old man is found to have elevated alanine aminotransferase and aspartate aminotransferase levels. He has no abdominal pain, nausea, or vomiting. The patient has used intravenous drugs in the past but denies significant alcohol use. His past medical history is negative for blood transfusions or excessive acetaminophen use. Physical examination findings are normal. Laboratory studies show high titers of IgG directed against the hepatitis C envelope protein.",
    "zh": "一名35岁男性患者，其丙氨酸转氨酶和天门冬氨酸转氨酶水平升高。他没有腹痛、恶心或呕吐。该患者过去曾使用静脉注射毒品，但否认大量饮酒。他的既往病史中没有输血或过量使用对乙酰氨基酚。体格检查结果正常。实验室研究显示针对丙型肝炎包膜蛋白的IgG抗体滴度高。"
  },
  "question": {
    "en": "Which of the following is the most likely reason that these antibodies do not confer effective immunity against the infection?",
    "zh": "以下哪项是这些抗体不能提供针对感染的有效免疫力的最可能原因？"
  },
  "options": {
    "A": {
      "en": "Envelope proteins are lost after recurrent viral replication",
      "zh": "包膜蛋白在反复病毒复制后丢失"
    },
    "B": {
      "en": "Envelope proteins are sequestered within hepatocytes",
      "zh": "包膜蛋白被隔离在肝细胞内"
    },
    "C": {
      "en": "Envelope proteins have low immunogenicity",
      "zh": "包膜蛋白的免疫原性较低"
    },
    "D": {
      "en": "Envelope proteins have variations in their antigenic structure",
      "zh": "包膜蛋白的抗原结构存在变异"
    },
    "E": {
      "en": "The antibodies do not have neutralizing properties",
      "zh": "抗体没有中和特性"
    }
  },
  "correct_answer": "D",
  "explanation": {
    "en": "Hepatitis C virus (HCV) has 6 or more genotypes and multiple subtypes that differ in genomic composition by as much as 30%-35%. This is largely due to the fact that the virion-encoded RNA-dependent RNA polymerase has no proofreading 3' > 5' exonuclease activity, which results in many errors during replication.\n\nAlthough most patients are infected with a single genotype, the high mutation rate leads to the development of distinct quasispecies within infected individuals over time. These variant strains differ primarily at hypervariable genomic regions, such as those found in the sequences coding for its envelope glycoproteins. The continuous generation of novel envelope proteins prevents infected individuals from mounting an effective immune response. As production of host antibodies against a quasispecies commences, that strain dies off and new ones take its place. The tremendous antigenic variety of HCV has significantly slowed efforts to develop an effective vaccine.\n\n(Choices A and B) The envelope proteins of HCV are not lost after recurrent viral replication nor are they sequestered within hepatocytes. These proteins are necessary for viral infectivity as they mediate membrane adhesion and fusion with host hepatocytes.\n\n(Choice C) Like most foreign (nonself) proteins, the envelope proteins of HCV are highly immunogenic.\n\n(Choice E) Host antibodies against HCV have neutralizing properties and are effective in eliminating more established hepatitis C quasispecies. It is the constantly emerging mutant strains that pose the greatest challenge to the host immune system.\n\nEducational objective:\nGenetic variations created during hepatitis C (HCV) replication result in marked variety in the antigenic structure of HCV envelope proteins. The production of host antibodies lags behind that of new mutant HCV strains, preventing infected individuals from mounting an effective immune response.",
    "zh": "丙型肝炎病毒（HCV）有6个或更多基因型和多种亚型，其基因组组成差异高达30%-35%。这主要是由于病毒编码的RNA依赖性RNA聚合酶没有校对3' > 5'外切核酸酶活性，导致复制过程中出现许多错误。\n\n尽管大多数患者仅感染一种基因型，但高突变率导致感染个体在一段时间内发展出不同的拟准种。这些变异株主要在高度可变基因组区域（例如编码其包膜糖蛋白的序列中）有所不同。新型包膜蛋白的持续产生阻止了感染个体产生有效的免疫反应。当针对拟准种产生宿主抗体时，该毒株会死亡，新的毒株取而代之。HCV巨大的抗原多样性大大减缓了开发有效疫苗的努力。\n\n（选项 A 和 B）HCV的包膜蛋白在反复病毒复制后不会丢失，也不会被隔离在肝细胞内。这些蛋白质对于病毒感染是必需的，因为它们介导与宿主肝细胞的膜粘附和融合。\n\n（选项 C）与大多数外源（非自身）蛋白质一样，HCV的包膜蛋白具有高度的免疫原性。\n\n（选项 E）针对HCV的宿主抗体具有中和特性，并且能有效消除更成熟的丙型肝炎拟准种。不断涌现的突变株对宿主免疫系统提出了最大的挑战。\n\n教育目标：\n丙型肝炎（HCV）复制过程中产生的基因变异导致HCV包膜蛋白的抗原结构出现显着多样性。宿主抗体的产生滞后于新的突变HCV毒株的产生，从而阻止了感染个体产生有效的免疫反应。"
  },
  "summary": {
    "en": "This question tests knowledge of Hepatitis C virus (HCV) and its ability to evade the immune system through antigenic variation. Specifically, it focuses on why antibodies against HCV envelope proteins may not confer effective immunity.\n\nThe key to solving this question is understanding the high mutation rate of HCV and its impact on the antigenic structure of its envelope proteins. This leads to the continuous generation of novel variants, making it difficult for the immune system to mount a sustained and effective response.",
    "zh": "本题考察了丙型肝炎病毒（HCV）及其通过抗原变异逃避免疫系统的能力。具体而言，它侧重于为什么针对HCV包膜蛋白的抗体可能不能提供有效的免疫力。\n\n解决此问题的关键是了解HCV的高突变率及其对包膜蛋白抗原结构的影响。这导致了新型变异株的持续产生，使得免疫系统难以产生持续有效的反应。"
  },
  "tags": "Hepatitis C virus; HCV; Antigenic variation; Viral replication; RNA-dependent RNA polymerase; Envelope proteins; Immunogenicity; Quasispecies; Viral evasion; Liver disease",
  "category": "Micro",
  "question_id": "44",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Micro 23\\44",
  "extracted_at": "2025-11-05T15:04:20.757136",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:12:15.999484",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}